MjLink Cannabis Business News and Press

Arkansas’ medical cannabis sales have hit $200 million this year, with patients spending $23.9 million at the state’s 38 licensed dispensaries in September, according to a local KNWA report.

Patients purchased 4,571 pounds of medical cannabis last month, the news outlet reported, and The Natural Relief Dispensary in Sherwood reported the most sales, with 431 pounds sold.

There are 92,035 patients enrolled in the medical cannabis program, according to KNWA.

“Patients spent approximately $800,000 daily in September on medical marijuana purchases,” Scott Hardin, a spokesperson for the Arkansas Department of Finance and Administration, told the news outlet. “Additionally, 4,571 pounds is the largest month for sales in 2022. Through the first nine months of 2022, patients have spent $205 million to obtain 36,600 pounds of medical marijuana. We anticipate 2022 sales will surpass the $264.9 million spent in 2021.”

RELATED: Arkansas Medical Cannabis Sales Top $23 Million in August

Individuals who apply to the Department of Air Force (DAF) but test positive for THC in the initial test could now be granted a second chance at enlisting. 

DAF announced Sept. 28 that it is implementing a two-year pilot program “that allows a retest for applicants who test positive for THC during the accession physical examination at the Military Entrance Processing Station.”

The new pilot program will allow applicants who test positive for THC to retest after 90 days if they are granted a THC waiver. If applicants pass the second test, they will be allowed to enlist in the DAF. In the past, an applicant who tested positive for THC would have received a permanent bar from entry into the DAF, according to the release.

The THC waiver will be granted to applicants who meet the qualification standards, which include:

This new policy is effective immediately and applies to the United States Air Force, U.S. Space Force, Air Force Reserve and Air National Guard, according to the release.

Over the next two years, DAF will collect and analyze data “to determine the suitability of adopting this as a permanent change to DAF recruiting and accessions policy,” according to the release.

HARRISBURG, Pa., Oct. 10, 2022 (GLOBE NEWSWIRE) -- PRESS RELEASE -- PA Options for Wellness, a provider of medical cannabis products in the Pennsylvania medical cannabis market, announced today the opening of two new medical marijuana dispensaries, bringing their retail footprint to a total of six locations throughout Pennsylvania.

The first of the two new dispensaries to open will be Kennett Square, located at 716 West Baltimore Pike in Delaware County, Penn. The Kennett Square location will open to patients on Monday, Oct. 17. The second location, located in State College, at 1653 North Atherton Street, will open to patients on Monday, Oct. 31. Both locations will feature on-site consultations, curbside delivery and an interactive pre-order menu with each dispensary open six days a week, from 10 a.m. to 8 p.m.

"Vytal Options, a PA Options for Wellness medical marijuana dispensary, is excited to bring our excellent patient service as well as quality products to the State College and Kennett Square areas," CEO and founder Thomas A. Trite said in a statement. "We were one of the first three medical marijuana Clinical Registrants approved by the Pennsylvania Department of Health to conduct research. After undergoing an extensive review process, we were selected by Penn State University and their College of Medicine to collaborate and research medical marijuana."

RELATED: PA Options for Wellness and Penn State’s College of Medicine Embark on 10-Year Journey to Study Medical Cannabis

To celebrate the grand openings, each location will kick off with a ribbon cutting ceremony at 9 a.m. ET, with members of the Chamber of Business, Penn State Research, and Balanced Veterans Network. A partnership with grower/processer FarmaceuticalRX has also been developed to support the dispensary openings.  A proprietary strain "Keystone OG" was created with the processing team at FarmaceuticalRX along with members of Vytal Options marketing and product development teams. The first 100 patients at each location will receive an exclusive, limited edition "Keystone OG" t-shirt to celebrate the collaboration. In addition, many of the state's top Medical Marijuana Grower Processers will be on hand at both locations, educating patients and handing out promotional materials. In addition, PA Options for Wellness will commemorate its latest dispensary openings by making a charitable contribution to organizations within the State College and Kennett Square communities.

LOS ANGELES, Oct. 7, 2022 /PRNewswire/ -- PRESS RELEASE -- Located in Eagle Rock, just off the Highway 134 and Figueroa interchange, Velvet Cannabis quietly opened its doors in late April as the company's first cannabis dispensary in Los Angeles. Founded by Matt Morea and Farid Harrison, Velvet brings a refined retail experience to the area, featuring a sleek and sophisticated design, an expert staff, and a cutting edge and reliable menu of world-class cannabis.

"We are extremely excited to bring an elevated experience in cannabis to the Los Angeles market," says Morea. "We have created a warm, beautifully designed destination that is comfortable, efficient, and highly personalized."

Velvet opened its first dispensary in May of 2020 in the San Francisco Bay Area suburb of Martinez. Since opening its doors, Velvet has been recognized as one of the best retail cannabis operators in the state. The company is a two-time winner of the Cannabis Business Times "Best Companies to Work For," and consistently earns one of the highest customer satisfaction ratings in California. Velvet plans to open additional retail locations in both Northern and Southern California and has a second Los Angeles location set to open in the Spring of 2023 in the Brentwood neighborhood.

RELATED: 2022 Best Cannabis Companies to Work For | Dispensary: #2 Velvet Cannabis

Cannabis enthusiasts, the canna-curious, recreational and medicinal users will find a highly curated selection of the best lab-tested CBD and THC products at Velvet, organized on a "good, better, best" pricing structure. The friendly and well-informed crew is happy to take guests through its selection of flowers, pre-rolls, vaporizers, concentrates, edibles, topicals, tinctures and more – featuring industry leading brands consumers have come to know as well as some of the newest products and brands to hit the market.

Wisconsin, Aug. 2022 — PRESS RELEASE — The Indigenous Cannabis Industry Association launches today to promote the exploration, development, and advancement of the cannabis industry for the benefit of all Indigenous communities. As a non-profit organization, ICIA is dedicated to the advocacy and empowerment of Indigenous cannabis businesses and aspiring entrepreneurs nationwide.

Founded by cannabis entrepreneur and member of the Bad River Band of the Lake Superior Tribe of Chippewa Indians Rob Pero, ICIA will create opportunities for Indigenous people in cannabis and empower the Indigenous community through policy, programming, and outreach initiatives.

“As stewards of environmental responsibility and with deep histories in agricultural expertise, Tribal governments and Indigenous people are uniquely positioned to add value to the cannabis industry,” says Pero, the founder and and president of ICIA. “ICIA will help tribal communities and Indigenous entrepreneurs navigate the cannabis industry, preserve Tribal sovereignty, further economic opportunities, and bring their unique perspectives into the national conversations around policy, sustainability, and equity.”

While in 2016 the National Congress of American Indians passed a resolution approving cannabis production to promote tribal self-determination and self-governance, create job opportunities, strengthen tribal governance, and promote equity in the cannabis industry, the current legal landscape of the cannabis industry is complex. As federal legalization of cannabis looms in the future, ICIA seeks to provide critical certainty for Indian Country cannabis economic development and long-term strategic analysis by building data and information on Tribes in cannabis.

“We are working directly with local representatives to support fair implementation and enforcement of sensible cannabis policies in our home state of Wisconsin,” says Pero. “We will continue to empower the Indigenous community and provide resources to Tribal Nations to influence policy at the state and federal levels and work to be a conduit of information for the community at large.”

New York Gov. Kathy Hochul told reporters this week that the state is “still on track” to launch adult-use cannabis sales this year, according to a Syracuse.com report.

During an Oct. 5 interview with the Advance Media New York editorial board, Hochul said the state will still realize its plan to have 20 adult-use dispensaries open by the end of 2022, with “another 20” opening roughly every month after that.

“We’re going to make sure that this is a model for the rest of the nation—especially with our desire to make sure that people who’ve been affected by the criminal justice system adversely ... have the opportunity to work in this area,” Hochul said, according to Syracuse.com.

Former New York Gov. Andrew Cuomo signed the Marijuana Regulation and Tax Act in March 2021 to legalize adult-use cannabis in the state. The rollout of the program largely stalled, however, until Hochul became governor in August 2021 after Cuomo resigned amid sexual harassment allegations.

Upon taking the reins last year, Hochul called a special session and appointed members to the New York Office of Cannabis Management (OCM) and Cannabis Control Board (CCB). She also signed legislation to allow the state’s licensed hemp farmers to grow cannabis for the adult-use market, as well as announced a fund and a “Seeding Opportunity Initiative” to promote social equity in the industry.

WAKEFIELD, Mass., Oct. 7, 2022 /PRNewswire/ -- PRESS RELEASE -- Curaleaf Holdings, Inc., an international provider of consumer products in cannabis, today announced the opening of its Scottsdale dispensary, located at 16277 N Greenway Hayden Loop, Scottsdale, AZ 85260. Curaleaf Scottsdale is the company's largest retail location in Arizona and one of its 16 dispensaries in the Grand Canyon State.

Located across the street from the world-renowned Tournament Players Club, Curaleaf Scottsdale is dedicated to providing high-quality cannabis products and service to patients and customers at all stages of their cannabis journey. The new location offers a wide array of products including high-quality flower and pre-rolls, Curaleaf Plant Precision gummies and topical gel, Select X Bites, Select Squeeze, Select Cliq and B NOBLE pre-rolls.

Curaleaf Scottsdale celebrates its soft opening today and is scheduled for an official grand opening event on Friday, Oct. 14. The grand opening will commence with a ribbon cutting at 10:30 a.m. followed by festivities throughout the weekend including swag giveaways, on-site entertainment, local food vendors and limited-time discounts.

"Following the completion of our Tryke acquisition this week, we are excited to deepen our roots in Arizona with the opening of Curaleaf Scottsdale," said Matt Darin, CEO of Curaleaf. "Not only is it our largest retail location in the state, but it is also led by a team of dedicated, knowledgeable professionals who are eager to serve the Scottsdale community."

For more information regarding Curaleaf's product offerings in Arizona, along with openings and hours of operation, please visit https://curaleaf.com/dispensary/arizona.

APOPKA, Fla., Oct. 7, 2022 /PRNewswire/ -- PRESS RELEASE -- Sanctuary Medicinals today announced the opening of its 13th medical cannabis dispensary in Florida.

Located westbound on W Atlantic Avenue, Sanctuary Delray Beach will be holding its Grand Opening celebration on Oct. 8. As the sixth operational Sanctuary dispensary in Palm Beach County, Delray Beach brings the number of Sanctuary locations in Florida to 13. Situated on State Road 806 and just three miles from I-95, Sanctuary Delray sits in the Lincoln Park Delray Shopping Mall between the High Point and Kings Point residential communities, which are to the north and south respectively.

"In the last quarter of 2022, we are thrilled to have continuous momentum with regards to our expansion in South Florida," said Jason Sidman, CEO of Sanctuary Medicinals. "We are growing at a steady rate, and this opening in Delray Beach both marks for our thirteenth location in the state and further solidifies Sanctuary's presence on the southeast coast of Florida."

With five of the last six new dispensary openings taking place in Palm Beach County, Sanctuary now has a strong stable of locations stretching from Jupiter down to Boca Raton and between Florida's Turnpike and I-95. As the year winds down, Sanctuary will continue expansion efforts in the northern part of the state while continuing to build on a string of new product approvals across multiple product categories to further enhance its menu offerings.

"We are excited to provide residing Delray Beach patients convenient access to medical cannabis," said Bill Dewar, Chief Operating Officer. "It's exciting to add yet another new city and location to the Sanctuary roster, but at the end of the day, we are always focused on expanding our territory and market reach. We plan to close 2022 on a strong note from an openings perspective."

WAKEFIELD, Mass., Oct. 7, 2022 /PRNewswire/ -- PRESS RELEASE -- Curaleaf Holdings, Inc., an international provider of consumer cannabis products, today announced the opening of its second Ocala dispensary, located at 9268 SE Maricamp Rd, Ocala, FL 34472. Curaleaf Ocala Maricamp is the company's 52nd location to open in the Sunshine State and 144th nationwide.

Curaleaf Ocala Maricamp is a substantial 3,216-square-foot facility featuring a drive-thru for convenience, whether patients are on the go or picking up a pre-order. Marion County's newest Curaleaf location offers a broad selection of vaporizers, edibles, concentrates, whole flower and innovative topical products, including Plant Precision Relieve Gel, Select Squeeze, Select X-Bites, Select Nano Bites, BlueKudu Chocolate, Select Live Rosin and its breakthrough vape hardware, Cliq by Select.

The new dispensary recently began welcoming patients and invites the Ocala community to its official grand opening event on Friday, Oct. 7. The grand opening will commence with a ribbon cutting at 10:00 a.m. followed by festivities throughout the day including swag giveaways, games, prizes and local vendors. Registered patients can enjoy a 50% discount at the new location all weekend.

In Ocala and throughout the state, Curaleaf is accepting and distributing donated supplies to those impacted by Hurricane Ian, and has also implemented a relief fund for its Florida team members.

For more information on Curaleaf's locations, patient resources and products in Florida, including updates to those dispensaries impacted by Hurricane Ian, please visit https://curaleaf.com/dispensary/florida.

With a month to go before Maryland voters cast their votes on cannabis legalization in the state, approval seems probable, according to recent data.

Nearly three-quarters (73%) of registered Maryland voters approve of cannabis legalization, while 23% disapprove and 4% have no opinion, according to a poll conducted by The Washington Post and the University of Maryland.

The poll asked respondents the following question: “Do you favor the legalization of the use of cannabis by an individual who is at least 21 years of age on or after July 1, 2023, in the state of Maryland?”

RELATED: Maryland Election Officials Finalize Adult-Use Cannabis Legalization for November Ballot

While Maryland voters are largely in favor of legalization, approval for cannabis legalization was also relatively similar across all education levels. Those with post-graduate degrees approve by a 75%-22% margin and those with high school or less approve by a 74%-20% margin. Those with bachelor’s degrees (73%-25%) and those with some college (70%-26%) also overwhelmingly approve of legalization.

Approval by gender was also relatively comparable. More than three-quarters (76%) of males said yes while 20% said no, and females were also in favor but slightly less so, with 69% approving and 26% opposing.

APOPKA, Fla., Oct. 6, 2022 /PRNewswire/ -- PRESS RELEASE -- Sanctuary Medicinals today announced the opening of its 12th medical cannabis dispensary in Florida.

Located just six miles west of the original Sanctuary Boca Raton opened in July 2022, Sanctuary's second Boca location will be holding a Grand Opening celebration on Oct. 7. As the fifth operational Sanctuary dispensary in Palm Beach County, Boca Raton Powerline brings the number of Sanctuary locations in Florida to 12. The 3,500-square-foot facility underwent a full interior renovation designed and executed by Vantage Builders, offering Sanctuary a foothold in the western half of Boca Raton to complement the existing dispensary further east on the coastline. Situated on Powerline Road just south of State Road 808, the second Sanctuary Boca Raton is right next to the Boca Grove Golf Course and roughly a mile northwest of the Boca Del Mar residential community.

"As the fall approaches, our Florida expansion planning is in full gear," said Jason Sidman, CEO of Sanctuary Medicinals. "Our second location in Boca Raton brings our complement of southeast Florida dispensaries to five, and this recent opening in Boca Raton constitutes our second location in the municipality."

Sanctuary continues to steadily grow and extend its footprint across the region, reaching patients across much of Saint Lucie, Martin and Palm Beach counties while continuing to deliver patients a convenient, accessible experience as well as a wide array of quality products. With tinctures, crumble, an expanded fruit chew selection and new flower strains now on its shelves, Sanctuary's product development efforts will expand to hash, full-spectrum edibles, a fuller concentrate menu and more in the coming months.

"It's very exciting to open a second location in Boca Raton," said Bill Dewar, Chief Operating Officer. "Our openings in this region are very selective, so we're excited to continue development into the fall and expand our brand and reach in the community."

President Joe Biden announced Oct. 6 that he has crafted a three-step plan to help fulfill his campaign promise of federal cannabis policy reform—and reactions to the news have since poured in from across the country.

As Cannabis Business Times reported, Biden's plan includes pardoning all federal offenses of the simple possession of cannabis, urging all state governors to pardon state-level offenses of simple cannabis possession, and asking Secretary of Health and Human Services Xavier Becerra and Attorney General Merrick Garland to initiate an administrative process to review how cannabis is scheduled under federal law.

Industry reactions to Biden's statement have been mostly positive, although some have argued that the proposal still does not go far enough to end the war on drugs and address the obstacles that state-licensed cannabis businesses face in their daily operations due to the conflict of federal and state laws.

Here, CBT has rounded up some of the reactions from lawmakers and industry on Biden's statement.

PRESS RELEASE - The list for pesticides that can be used on cannabis without being a violation of the Pesticide Applicators' Act has been updated. Please note the following products have been added:

To view the updated list, click here for a pdf or click here for an Excel form. For questions regarding this change, contact Jolynn Morris at (303) 869-9060 or email [email protected].

The Colorado Department of Agriculture (CDA) is currently reviewing pesticide labels upon request and maintaining a list of products whose label it has reviewed that it believes could be used on marijuana without violating 35-10-117(1)(i), as long as the applicator follows the label directions.

Please be sure to review the list; pesticide products may be removed from the allowed products list if the registrant has not renewed their pesticide product with the department. Use of unregistered pesticides on cannabis would be a violation of the Pesticide Applicators' Act.

Stay Informed

President Joe Biden announced Oct. 6 the first steps toward fulfilling his campaign promise of federal cannabis policy reform.

“As I often said during my campaign for President, no one should be in jail just for using or possessing marijuana,” Biden said in a public statement. “Sending people to prison for possessing marijuana has upended too many lives and incarcerated people for conduct that many states no longer prohibit. Criminal records for marijuana possession have also imposed needless barriers to employment, housing, and educational opportunities. And while white and Black and brown people use marijuana at similar rates, Black and brown people have been arrested, prosecuted, and convicted at disproportionate rates.”

The first step in Biden’s three-step plan is pardoning all federal offenses of the simple possession of cannabis, according to the statement.

“I have directed the Attorney General to develop an administrative process for the issuance of certificates of pardon to eligible individuals,” Biden said. “There are thousands of people who have prior Federal convictions for marijuana possession, who may be denied employment, housing, or educational opportunities as a result. My action will help relieve the collateral consequences arising from these convictions.”

Second, Biden is urging all state governors to pardon state-level offenses of simple cannabis possession.

“Just as no one should be in a Federal prison solely due to the possession of marijuana, no one should be in a local jail or state prison for that reason, either,” he said.

Paula Overby, running for the U.S. House on the third-party Legal Marijuana Now ticket in Minnesota’s 2nd Congressional District, died Oct. 5.

Overby, 68, died of complications from a heart valve problem after two weeks in the hospital, her son, Tyler Overby, told the media, The Associated Press reported.

Overby was one of three major-party candidates in Minnesota’s 2nd District—one of the most hotly contested districts in the U.S.—which includes Democratic incumbent Rep. Angie Craig and Republican challenger Tyler Kistner. A two-term congresswoman, Craig defeated Kistner, 48.2%-46%, in the 2020 election. It was the closest congressional race in the state that year.

Overby, who previously ran for the 2nd Congressional District as an Independent in 2014, was expected to shake up the mostly suburban seat’s 2022 race, which Republican National Committee Chair Ronna McDaniel said Oct. 4 was projected to be the second-most expensive congressional contest across the entire country in 2022.

As of the end of June, Craig’s reelection campaign had $4.7 million in the bank, the AP reported. That hefty financial support from mostly small donors comes as Democratic strategists warn that third-party candidates, like Overby, could serve as “spoilers” by drawing voters away from Democrats like Craig, who supports cannabis legalization.

As a third-party candidate, Overby was running on a ticket with a primary platform to oppose drug prohibition. The Legal Marijuana Now Party was established in 1998 in St. Paul, Minn., and became a major party in the state in 2018, when state auditor candidate Michael Ford received 5.3% of the vote. 

Patient satisfaction with the Ohio Medical Marijuana Control Program (OMMCP), which recently hit $1 billion in sales, seems to be improving, according to a recent report from The Ohio State University’s Drug Enforcement and Policy Center and the OMMCP. The report, “Ohio Medical Marijuana Control Program at Four Years: Evaluating Satisfaction and Perception,” surveyed more than 2,500 people and found, for the first time in the history of the four-year report, more respondents are satisfied with the state’s medical program than not.

“For the first time in four years, patients and prospective patients of the [OMMCP], have expressed higher levels of satisfaction than dissatisfaction suggesting that as OMMCP matured, Ohio has successfully improved its existing program to garner a growing level of general satisfaction,” the report states.

While patients were generally satisfied with product safety, patient experience and dispensary access, participants noted concerns over pricing and protections for employees using medical cannabis.  

When ranking a series of statements on a scale, more than 50% of survey participants responded “Strongly Agree” to the following: “I trust the safety or products available in legal dispensaries,” “Dispensary employees support a positive patient experience in the purchasing of medical marijuana products” and “Legal dispensaries make medical marijuana easily accessible for me.”

However, more than 50% of survey participants also agreed with the statements “The price of marijuana in legal dispensaries is too high,” “Patients are not given legal protections for employment” and “Self-cultivation is not permitted (home grow)."

The number of active patients in the program increased 44% from 107,134 to 154,614 between August 2021 and August 2022, according to the report. However, according to the OMMCP, there are 278,902 unique patients who have purchased cannabis during the life of the program, which launched in January 2019, suggesting that not all are renewing their medical cards. Patients must update their medical cards yearly by getting a new recommendation from an approved provider and paying a fee.

The Connecticut Department of Consumer Protection (DCP) announced Oct. 5 that it has opened the process for three cannabis product packager applicants to advance in the licensing process.

The Social Equity Council approved Charles W. Jackson, Bay Breeze Botanicals Inc. and Dutch LLC through the state’s Social Equity Lottery, and the applicants have been notified by the DCP that they can complete the next steps for licensure.

The three applications represent the maximum number of Social Equity Licenses available for the product packager license type in the first lottery round, according to the announcement, although additional licenses will be available in future lotteries.

The approved applicants must now submit additional information for the required background check and provisional license application, which the DCP will review. Qualifying applicants must then pay the required licensing fees and proceed with the next phase of licensure.

The remaining social equity applicants that were not selected in the Social Equity Lottery will be added to Connecticut’s General Lottery, which will be conducted by the UConn School of Pharmacy.

NEW YORK--(BUSINESS WIRE)--PRESS RELEASE--Columbia Care Inc., one of the largest and most experienced cultivators, manufacturers and providers of cannabis products in the U.S., announced it has launched its new cannabis-infused edibles brand, Hedy, in six markets. A variety of fast-acting chocolates and gummies are now available in Arizona, Colorado, Delaware, Massachusetts, Missouri and Virginia.

“We are so excited to bring Hedy to life and share with our patients and customers across the country. Our team wanted to create a brand, as well as a bright, fun and inviting visual representation that truly reflects the uplifting edibles experience,” said BJ Carretta, SVP of Brands, Columbia Care. “Everything from the packaging to the flavors, and eventually the various forms underneath the brand, are all part of this authentic interaction with Hedy. We developed the brand in coordination with our cultivation and marketing teams, using insights generated from our unique technological platforms, such as Forage, that help us better understand what our community is looking for. We believe this is the right product to meet our patients and customers where they are in their cannabis journey, with an approachable form factor that is of the highest quality and designed to provide a consistent experience, no matter the market.”

In its first six markets, Hedy gummies will be available in three flavors: cherry lime, green apple and watermelon. Colorado has also launched chocolate drops. The 5mg or 10mg THC gummies come in packages of 10 or 20, depending on the market, and are powered by leading edibles ingredient company Azuca and its fast-acting TiME INFUSION formulations to provide quick-onset in 5-15 minutes.

In the coming months, the company will introduce more options, and will have Hedy available in more markets. Additionally, existing Columbia Care edible brands such as NectarBee, will be converting to the Hedy brand over time.

For more information about Hedy, visit www.hedyedibles.com.

CLACKAMAS, Ore., Oct. 6, 2022 /PRNewswire/ -- PRESS RELEASE -- Wyld, a cannabis edibles brand in the U.S., is expanding its family of brands with the launch of Good Tide. The solventless hash rosin edible brand will be available in Oregon, California and Colorado markets in fall 2022.

Good Tide gummies are made with premium solventless hash rosin that delivers a true-to-plant high. The rosin includes naturally occurring terpenes and minor cannabinoids from the cannabis plant which harmonize with the tropical real-fruit ingredients to create a delicious, full spectrum experience. Good Tide offers a trio of irresistible vegan flavors including Mango, Guava and Pineapple.

"Wyld is proud to welcome Good Tide to our portfolio. Not only does Good Tide perfectly complement Wyld's current offerings, it meets our sustainability initiatives. This brand is Climate Neutral Certified, produced with a carbon neutral footprint, 100% renewable energies, and comes with a customized plastic-free, fully recyclable, and compostable packaging," said CEO Aaron Morris. "We are excited for this solventless addition and to keep pushing our internal sustainability standards to new levels. I can't wait to share with you all our efforts rolling out in 2023!"

Good Tide is here to have fun, do good and make waves. By staying true to what they believe in with their products and approach, Good Tide challenges norms and sets the bar higher. Take a tropical vacation and enjoy all that cannabis has to offer.

For more information regarding Wyld's newest venture, Good Tide, and its latest product offerings, please visit GoodTideCannabis.com.

MIAMI, Oct. 06, 2022 (GLOBE NEWSWIRE) -- PRESS RELEASE -- Ayr Wellness Inc., a vertically integrated U.S. multi-state cannabis operator (MSO), is announcing the rollout of its premium live resin concentrates and vapes brand HAZE in Florida.

Having recently celebrated surpassing 50 retail stores throughout Florida, the introduction of Hydrocarbon Extraction products to its menus marks another major milestone for Ayr in the Sunshine State.

“Ayr has carefully crafted a brand portfolio that appeals to a wide array of consumers throughout the value spectrum, providing quality products at every price point,” said Jonathan Sandelman, founder and CEO of Ayr. “HAZE represents a premium experience at an attractive price point, enabled by the cultivation and production improvements since we took over the Liberty Health Sciences’ Gainesville facility last year.”

HAZE premium live resin concentrates and vapes are formulated for rapid onset and deliver a full-sensory experience. Products available at launch include live resin vape cartridges, live badder and live sugar. Strains include WAP #27, Caesar, 8” Bagel, Gorilla Glue, Mr. Nasty and Ruby Slippers.

Following Hurricane Ian, 47 of Ayr’s 51 Florida stores are currently open, and the company’s Bonita Springs store will reopen on Friday, Oct. 8. In an effort to ensure medical marijuana patients have access to medicinal treatments, the company is actively working to reopen locations in Cape Coral, Port Charlotte, and Sebring once it is safe and compliant to do so.